V. Bertrand et al., EFFECTS OF MURINE RECOMBINANT INTERLEUKIN-10 ON THE INFLAMMATORY DISEASE OF RATS TRANSGENIC FOR HLA-B27 AND HUMAN BETA-2-MICROGLOBULIN, European cytokine network, 9(2), 1998, pp. 161-170
Rats transgenic for HLA-B27 and human beta 2-microglobulin develop a s
pontaneous, multisystem, inflammatory disease that resembles human B27
-associated disease and that involves the gut mucosa, This model predo
minantly affects the colon and is characterized by an extensive infilt
ration of the mucosa by inflammatory cells, largely composed of mononu
clear cells. Ire addition, an increased plasma level of nitric oxide (
NO)-derived metabolites was described in this model, Deficiency in the
anti-inflammatory cytokine, interleukin-10 (IL-10), leads to the deve
lopment of colitis in IL-10 knockout mice, suggesting that IL-10 plays
a major role in the control of gut inflammation. The objectives of th
is work were to study the mechanisms of the inflammatory bowel disease
(IBD) in HLA-B27 rats and to determine the effects of treatment with
IL-10, The 33-3 line of HLA-B27 recombinant rats with established dise
ase was treated in two consecutive experiments with murine recombinant
IL-10 for five weeks. Assessment of the effect of this treatment was
performed, based on clinical, histological and biological (myeloperoxi
dase and inducible NO synthase activities; tumor necrosis factor-alpha
, interferon-gamma, CD3, iNOS and beta-actin mRNA expression. In 33-3
rats with established disease, mesenteric lymph nodes were hyperplasti
c, and colonic cellularity and MPO and iNOS activities in the colonic
mucosa were increased without any detectable effects of IL-10 administ
ration. IFN-gamma and iNOS mRNA were only detected in the colon of tra
nsgenic rats. Despite a lack of effect on disease expression, IL-10 st
rikingly reduced the level of IFN-gamma mRNA in gut mucosa, Up-regulat
ion of IFN-gamma mRNA suggests that the IBD of HLA-B27 rats is mediate
d by T-helper 1 lymphocytes, Sustained administration of IL-10, in HLA
-B27 rats with established disease, efficiently inhibited IFN-gamma mR
NA expression but did not influence disease expression: these results
indicate that IFN-gamma may exert a critical role at an earlier stage
of the disease rather in the maintenance of the lesions.